Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Immix Biopharma (IMMX)

Annual Return

Over the past 3 years, IMMX has had an average annual return of +60.60%, outperforming the benchmark SPY, which returned +22.45% annual.

Since Dec 16, 2021, IMMX has had an average annual return of +20.50%, outperforming the benchmark SPY, which returned +12.92% annual.

202620252024202320222021
+61.37%+137.71%-68.21%+202.18%-35.67%-3.00%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+11.47%+38.42%+12.89%-1.98%+0.78%-6.22%+61.37%
2025-11.83%-8.25%-5.61%+25.58%+10.91%-11.54%+31.40%-18.38%-5.85%+81.81%+11.84%+23.07%+137.71%
2024-44.80%-12.31%-8.36%-29.31%-2.77%-6.16%+4.54%+3.39%-30.37%+7.39%+31.86%+4.28%-68.21%
2023+13.53%-19.99%-12.51%+35.71%-18.22%+33.18%-23.42%-1.46%+68.49%+5.85%+41.16%+35.42%+202.18%
2022+14.05%-26.60%-19.13%-42.74%+55.08%+21.49%-6.14%-25.42%-25.27%-26.47%+20.99%+89.26%-35.67%
2021-3.00%-3.00%

Drawdown analysis of Immix Biopharma (IMMX)

The maximum drawdown for the IMMX was -88.89%, occurring on Nov 10, 2022. Recovery took 275 trading sessions.

The current IMMX drawdown is -24.10%.

Since Dec 16, 2021 IMMX has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 3 times
  • 20% or more: 5 times
  • 10% or more: 5 times
DepthStartTo BottomBottomTo RecoverEndTotal
-88.89%Jan 5, 2022214Nov 10, 2022275Dec 15, 2023489
-81.57%Dec 15, 2023200Oct 3, 2024298Dec 11, 2025498
-39.84%Dec 11, 202520Jan 12, 202622Feb 12, 202642
-26.71%Mar 17, 20268Mar 27, 2026OngoingOngoingOngoing
-26.25%Dec 17, 20214Dec 23, 20216Jan 3, 202210
-7.77%Feb 25, 20262Feb 27, 20265Mar 6, 20267
-4.40%Mar 11, 20262Mar 13, 20261Mar 16, 20263
-4.31%Feb 17, 20261Feb 18, 20263Feb 23, 20264
-1.34%Feb 12, 20261Feb 13, 20261Feb 17, 20262